Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael C. Milone
University of Pennsylvania, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Trustees of the University of Pennsylvania
Other : Dr. Milone has a financial interest in intellectual property that is the subject of patent applications assigned to the University that are being tested in a clinical trial funded by this award. This type of financial interest is an SFI under Penn's governing policy, even if the IP is not licensed and even if no royalties were received. In this case, the IP has been licensed and Dr. Milone reported receipt of $10,000 in royalties during the past 12 months pursuant to the license.
NA
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
Overall Narrative Our goal is to develop next generation immunotherapy for hematologic malignancies which strike more than 200,000 people every year in the United States. Our approach involves the development of next generation therapies with chimeric antigen receptor (CAR) T cells, involving innovative combinations of CAR T cells and genetic editing with CRISPR/Cas9 technology to be tested in four clinical trials. Our team has provided paradigm shifting impact in B cell malignancies and these projects have the potential to transform therapies for numerous cancers beyond acute leukemia.
Filed on January 16, 2018.
Tell us what you know about Michael C. Milone's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.